Liquidia surges after United Therapeutics request for preliminary injunction denied


law legal technology

utah778/iStock via Getty Images

Update 6:20pm: Adds new United Therapeutics lawsuit against Liquidia.

Liquidia (NASDAQ:LQDA) jumped 12% in after hours trading after a judge denied United Therapeutics request for a preliminary injunction over lung-disease drug Yutrepia.

“Although Plaintiff has shown a likelihood of success as to infringement

Source link

Leave A Reply

Your email address will not be published.